Search results for " Method."

showing 10 items of 10241 documents

TheMAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression

2006

This study investigated the possible association of the MAOA T941G gene variant with differential antidepressant response to mirtazapine and/or paroxetine in 102 patients with major depression (DSM-IV criteria) participating in a randomized double-blind controlled clinical trial. Female mirtazapine-treated patients homozygous for the T-allele had a significantly faster and better treatment response than TG/GG-patients. In males, we failed to show an association between MAOA T941G gene variant and mirtazapine response. In the paroxetine-treated group, there were no significant differences in treatment response between MAOA T941G genotype groups. Time course of response and antidepressant eff…

AdultMaleOncologymedicine.medical_specialtyTime FactorsGenotypeGenetic LinkageMirtazapineMirtazapineMianserinPolymorphism Single NucleotideCellular and Molecular NeuroscienceDouble-Blind MethodGene FrequencyInternal medicineGenotypemedicineHumansAlleleMonoamine OxidaseGenotypingGenetics (clinical)Depressive Disorder MajorSex Characteristicsbusiness.industryMiddle AgedParoxetineAntidepressive AgentsClinical trialParoxetinePsychiatry and Mental healthTreatment OutcomeEndocrinologyAntidepressantFemalebusinessReuptake inhibitormedicine.drugAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics
researchProduct

Zolmitriptan inhibits neurogenic inflammation and pain during electrical stimulation in human skin.

2014

Background Triptans are agonists to 5-HT 1B/D/F receptors, which are present on nociceptive neurons not only within but also beyond the trigeminal system. The aim of this study was to investigate whether zolmitriptan interacts with peptidergic nociceptive afferents in human skin. Methods Twenty participants (13 women, median age: 25; interquartile range: 23–26 years) entered the randomized, double-blind, cross-over study. Electrically induced neurogenic flare and pain was assessed after either placebo or zolmitriptan on the ventral thigh. Mechanical pain thresholds were investigated at baseline and after electrical stimulation at the stimulation site. Results The size of the neurogenic flar…

AdultMalePain ThresholdMigraine DisordersPainStimulationZolmitriptanHuman skinTriptansPharmacologyPlaceboYoung AdultDouble-Blind MethodPhysical StimulationmedicineHumansNeurons AfferentOxazolidinonesPain MeasurementSkinNeurogenic inflammationCross-Over Studiesbusiness.industryNociceptorsElectric StimulationTryptaminesSerotonin Receptor AgonistsAnesthesiology and Pain MedicineNociceptionAnesthesiaHyperalgesiaFemalemedicine.symptomNeurogenic Inflammationbusinessmedicine.drugEuropean journal of pain (London, England)
researchProduct

Activation of the cortical pain network by soft tactile stimulation after injection of sumatriptan.

2006

The anti-migraine drug sumatriptan often induces unpleasant somatosensory side effects, including a dislike of being touched. With a double-blind cross-over design, we studied the effects of sumatriptan and saline on perception (visual analogue scale) and cortical processing (functional magnetic resonance imaging) of tactile stimulation in healthy subjects. Soft brush stroking on the calf (n = 6) was less pleasant (p < 0.04) and evoked less activation of posterior insular cortex in the sumatriptan compared to the saline condition. Soft brushing activated pain processing regions (anterior insular, lateral orbitofrontal, and anterior cingulate cortices, and medial thalamus) only in the sumatr…

AdultMalePain ThresholdPainStimulationSomatosensory systemInsular cortexDouble-Blind MethodPhysical StimulationmedicineImage Processing Computer-AssistedHumansPain MeasurementSkinCerebral CortexBrain MappingSensory stimulation therapyCross-Over Studiesmedicine.diagnostic_testSumatriptanMagnetic Resonance ImagingSerotonin Receptor AgonistsOxygenSumatriptanAnesthesiology and Pain MedicineNociceptionNeurologyTouchNociceptorFemaleNeurology (clinical)Functional magnetic resonance imagingPsychologyNeurosciencemedicine.drugPain
researchProduct

Short-term effects of kinesio taping in the treatment of latent and active upper trapezius trigger points : two prospective, randomized, sham-control…

2019

Este es el artículo que se ha publicado de forma definitiva en: https://www.nature.com/articles/s41598-019-51146-4 The presence of myofascial trigger points (MTrPs) is one of the most common causes of musculoskeletal problems and may lead to limited professional activity. Among the various treatment methods proposed for MTrPs, Kinesio Taping (KT) is a non-invasive, painless, and less time-consuming method with fewer side efects that has become widely used as a therapeutic tool in a variety of prevention and rehabilitation protocols. The aim of the study was to evaluate the immediate and short-term efcacy of the space correction KT technique in patients with latent or active MTrPs in the upp…

AdultMalePain ThresholdUpper trapeziusmedicine.medical_specialtyAdolescentFisioteràpiaLateral flexionmedicine.medical_treatmentlcsh:MedicineArticleYoung Adult03 medical and health sciences0302 clinical medicineDouble-Blind MethodIntervention TypeSistema musculoesquelético - Heridas y lesiones - Tratamiento.HumansMedicineIn patientProspective StudiesRange of Motion ArticularMyofascial pain syndromes - Treatment.lcsh:ScienceLead (electronics)Myofascial Pain SyndromesNeck PainMultidisciplinaryRehabilitationbusiness.industryVendajes - Uso terapéutico.Rehabilitationlcsh:RTrigger Points030229 sport sciencesSíndrome de dolor miofascial - Tratamiento.Pain managementAthletic TapeCervical VertebraeSuperficial Back MusclesPhysical therapyFemalelcsh:QAnalysis of varianceMusculoskeletal system - Wounds and injuries - Treatment.businessRange of motionBandages and bandaging - Therapeutic use.030217 neurology & neurosurgery
researchProduct

How much Is needed? Comparison of the effectiveness of different pain education dosages in patients with fibromyalgia

2019

AbstractObjectiveTo assess the effect of different dosages of pain neuroscience education (PNE) programs on central nociceptive processing in patients with fibromyalgia. Second, to compare the effects of different dosages of PNE programs on numerical pain rating scale (NPRS), disability, and psychological variables.DesignSingle-blind randomized controlled trial.SettingThree fibromyalgia centers in Spain (Valencia, Alcorcón, Alcalá de Henares).SubjectsSeventy-seven patients with fibromyalgia.MethodsParticipants were randomized to four groups of PNE: 1) high-dose PNE (N = 20), 2) low–concentrated dose PNE (N = 20), 3) diluted low-dose PNE (N = 20), and (4) control treatment (N = 17), conducte…

AdultMalePain Thresholdmedicine.medical_specialtyFibromyalgiaTime FactorsDoseAnxietylaw.invention03 medical and health sciences0302 clinical medicinePatient Education as TopicRandomized controlled trial030202 anesthesiologylawFibromyalgiaPressuremedicineHumansSingle-Blind MethodIn patientAgedPain MeasurementControl treatmentbusiness.industryCatastrophizationLarge effect sizeDiffuse noxious inhibitory controlPain PerceptionGeneral MedicineMiddle Agedmedicine.diseasePostsynaptic Potential SummationAnesthesiology and Pain MedicinePhysical therapyFemalePain catastrophizingNeurology (clinical)Human medicinebusiness030217 neurology & neurosurgeryPain medicine
researchProduct

Low morphine doses in opioid-naive cancer patients with pain

2006

Cancer pain can be managed in most patients through the use of the analgesic ladder proposed by the World Health Organization. Recent studies have proposed to skip the second "rung" of the ladder by using a so-called "strong" opioid for moderate pain. However, usual doses of strong opioids commonly prescribed for the third rung of the analgesic ladder may pose several problems in terms of tolerability in opioid-naive patients. The aim of this multicenter study was to evaluate the efficacy and tolerability of very low doses of morphine in advanced cancer patients no longer responsive to nonopioid analgesics. A sample of 110 consecutive opioid-naive patients with moderate-to-severe pain were …

AdultMalePainWHO method cancer pain opioids morphineOpioidDose-Response RelationshipQuality of lifeNeoplasmsWHO methodMedicineHumansCancer painOpioid peptideGeneral NursingNursing (all)2901 Nursing (miscellaneous)AgedAnalgesicsDose-Response Relationship DrugCancer pain; Morphine; Opioids; WHO method; Adult; Aged; Analgesics Opioid; Dose-Response Relationship Drug; Female; Humans; Male; Middle Aged; Morphine; Neoplasms; Pain; Treatment Outcome; Anesthesiology and Pain Medicine; Neurology (clinical); Neurology; Nursing (all)2901 Nursing (miscellaneous)Morphinebusiness.industryCancerMiddle Agedmedicine.diseaseAnalgesics OpioidClinical trialOpioidsTreatment OutcomeAnesthesiology and Pain MedicineTolerabilityOpioidNeurologyAnesthesiaMorphineFemaleNeurology (clinical)DrugbusinessCancer painmedicine.drug
researchProduct

In vivo molecular imaging of gastric cancer by targeting MG7 antigen with confocal laser endomicroscopy.

2013

Background and study aims: In vivo molecular imaging represents a powerful tool for the immediate diagnosis of gastric cancer. In this study, the monoclonal antibody MG7, which is a specific molecular marker against gastric cancer, was labeled with fluorescent agents to enable in vivo real-time imaging by confocal laser endomicroscopy (CLE). Patients and methods: In vivo molecular imaging was performed in tumor-bearing mice from two kinds of human gastric cancer cell lines. Xenograft tumors were visualized in vivo first with a whole-body fluorescent imaging device and then by CLE using fluorescently labeled MG7 antibody. Gastric cancerous tissue and noncancerous mucosa from human biopsies o…

AdultMalePathologymedicine.medical_specialtyConfocalMiceAntigenIn vivoAntigens NeoplasmStomach NeoplasmsCell Line TumorBiopsymedicineAnimalsHumansSingle-Blind MethodAgedAged 80 and overMice Inbred BALB CMicroscopy Confocalmedicine.diagnostic_testbusiness.industryCarcinomaGastroenterologyCancerAntibodies MonoclonalMiddle Agedmedicine.diseaseImmunohistochemistryMolecular ImagingMicroscopy FluorescenceImmunohistochemistryFemaleMolecular imagingbusinessEx vivoEndoscopy
researchProduct

Fluorescence Microscopy as a Diagnostic Tool for Dermatophytosis.

2016

Dermatophytosis is a superficial fungal infection of keratinized tissues. Dermatophytes can cause discomfort but are not usually life threatening. However, the infection can spread and may lead to systemic fungal infections in immunocompromised patients. Currently available diagnostic methods include potassium hydroxide (KOH) testing and periodic acid-Schiff (PAS) staining. However, most diagnostic techniques cannot be performed rapidly; days to weeks may be required for conclusive results. Certain dermatophytes autofluoresce and can be observed under fluorescence microscopy. The authors examined a series of 24 cases of hematoxylin and eosin-stained dermatophytoses using fluorescence micros…

AdultMalePathologymedicine.medical_specialtyDiagnostic methodsAdolescentH&E stainDermatologyPeriodic acid–Schiff stainPathology and Forensic Medicine030207 dermatology & venereal diseases03 medical and health sciencesYoung Adult0302 clinical medicineTineaMicroscopyFluorescence microscopeMedicineHumans030212 general & internal medicineChildAgedAged 80 and overbusiness.industryGeneral MedicineMiddle AgedFluorescenceStainingClinical PracticeMicroscopy FluorescenceFemalebusinessThe American Journal of dermatopathology
researchProduct

Survival of Adults with Acute Lymphoblastic Leukemia in Germany and the United States

2014

BackgroundAdulthood acute lymphoblastic leukemia (ALL) is a rare disease. In contrast to childhood ALL, survival for adults with ALL is poor. Recently, new protocols, including use of pediatric protocols in young adults, have improved survival in clinical trials. Here, we examine population level survival in Germany and the United States (US) to gain insight into the extent to which changes in clinical trials have translated into better survival on the population level.MethodsData were extracted from the Surveillance, Epidemiology, and End Results database in the US and 11 cancer registries in Germany. Patients age 15-69 diagnosed with ALL were included. Period analysis was used to estimate…

AdultMalePediatricsmedicine.medical_specialtyAdolescentNon-Clinical MedicineEpidemiologyScienceLymphoblastic LeukemiaBiostatisticsHematologic Cancers and Related DisordersGermanyLeukemiasEpidemiologyHumansMedicineStatistical MethodsYoung adultSurvival analysisAgedHealth Care PolicyMultidisciplinaryRelative survivalbusiness.industryStatisticsQRCancers and NeoplasmsCancerHematologyMiddle AgedPrecursor Cell Lymphoblastic Leukemia-LymphomaAcute Lymphoblastic Leukemiamedicine.diseaseSurvival AnalysisUnited StatesClinical trialOncologyUnited States ; age groups ; cancer treatment ; German people ; Germany ; cancer detection and diagnosis ; acute lymphoblastic leukemia ; leukemiasMedicineFemaleHealth StatisticsbusinessMathematicsResearch ArticleRare diseasePLoS ONE
researchProduct

Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study.

2001

Objective: To determine incidence of and risk factors for sudden unexpected death in epilepsy (SUDEP). Methods: Three epilepsy centers enrolled 4,578 patients and prospectively followed these patients for 16,463 patient-years. The cohort was screened for death annually. Deaths were investigated to determine whether SUDEP occurred. Potential risk factors were compared in SUDEP cases and in controls enrolled contemporaneously at the same center. Results: Incidence of SUDEP was 1.21/1,000 patient-years and was higher among women (1.45/1,000) than men (0.98/1,000). SUDEP accounted for 18% of all deaths. Occurrence of tonic-clonic seizures, treatment with more than two anticonvulsant medications…

AdultMalePediatricsmedicine.medical_specialtyTime FactorsAdolescentSudden deathCohort StudiesEpilepsyDeath SuddenRisk FactorsCause of DeathEpidemiologymedicineHumansProspective StudiesRisk factorProspective cohort studyChildCause of deathAgedAged 80 and overEpilepsybusiness.industryIncidenceInfant NewbornInfantepilepsy death sudepMiddle Agedmedicine.diseaseSurgeryChild PreschoolCohortSettore MED/26 - NeurologiaFemaleNeurology (clinical)businessEpidemiologic MethodsCohort studyNeurology
researchProduct